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Abstract
Few publications report the possibility of torsade de pointes (TdP) type tachycardia and
ventricular fibrillation occurring in patients with prolonged QT syndrome in the course of
hypothyroidism. The authors present the case of a 51-year-old woman with Hashimoto disease
and hypothyroidism, inadequately supplemented with L-thyroxine. This patient was admitted
to the ward with symptoms of hypometabolic crisis. She was diagnosed with shock and had
marked sinus bradycardia with a QT interval prolongation of 0.8 s and paroxysmal TdP-type
ventricular tachycardia. TdP was triggered by R-on-T ventricular extrasystoles. Laboratory
tests revealed profound hypothyroidism. As pharmacological treatment of the arrhythmia and
bradycardia was ineffective, an endocavital electrode was introduced. As a result of ventricular
stimulation with a frequency of 90/min, shortening of the QT interval and disappearance of
the cardiac arrhythmia and cardiogenic shock symptoms were obtained. L-thyroxine was
administered and two days later ventricular stimulation was discontinued. When corrected for
heart rate, the QT interval (QTc) was 0.43 s and no QT prolongation was detected in the
course of a follow-up period of several months, during which L-thyroxine supplementation was
adequate. Hypothyroidism may be the cause of life-threatening arrhythmias secondary to acqu-
ired long QT syndrome. Ventricular electrostimulation proved to be a life-saving intervention
in this case in which prolonged QT syndrome and ventricular cardiac arrhythmias complica-
ted hypometabolic crisis. (Cardiol J 2007; 14: 198201)
Key words: hypothyroidism, long QT interval, torsade de pointes
Introduction
It is well known that an excess or deficit of thy-
roid hormones affects the cardiovascular system.
A typical ECG in hypothyroidism shows bradycar-
dia, a low voltage of the QRS complexes, elonga-
tion of the PQ and flattening or inverting of the
T waves [1]. However, less well known is the fact
that hypothyroidism may be the cause of atrioven-
tricular blocks and of acquired long QT syndrome
(LQTS). Only a few publications report life-threatening
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paroxysmal ventricular fibrillation occurring in
patients with prolonged QT syndrome in the course
of hypothyroidism [24]. The most common caus-
es of acquired LQTS are drugs (anti-arrhythmic, an-
tipsychotic, tricyclic antidepressant or cisapride),
organic heart disease, dyselectrolytaemia (hypoka-
laemia, hypocalcaemia and hypomagnesaemia) and
metabolic factors [5]. It is important to emphasise
that hypothyroidism is not mentioned as one of the
causes of acquired LQTS even in significant sour-
cebooks, and there are only a few notes in mono-
graphs dealing with the subject [6, 7].
Case report
A 51-year-old woman with hypothyroidism in
the course of Hashimoto disease diagnosed three
years previously (a high titer of thyreoperoxidase
antibodies; Table 1) was hospitalised because of
deterioration in her general condition and distur-
bances of consciousness. During the transport to
hospital torsade de pointes (TdP)-type tachycardia
occurred (Fig. 1A). On admission to Casualty and
then to The Department of Internal Diseases and
Endocrinology she was in a serious general condi-
tion, lethargic and without logical verbal contact.
Data on her history received from a family member
disclosed that for the last few weeks she had reduced
the dose of L-thyroxine and tri-iodothyronine taken
without prior consultation with her endocrinologist.
Physical examination revealed signs of hy-
pometabolic crisis (Table 1), and therefore 200 mg
of hydrocortisone were administrated intravenous-
ly. Because of anamnesis of persistent headaches
over three weeks, nausea, generalised muscle weak-
ness and a positive Babinski sign on the right side,
which were present on physical examination, com-
puted tomography and opthalmological examination
were performed with no abnormal findings.
In ECG and in telemetric monitoring sinus
bradycardia was recorded with marked QT interval
prolongation (Fig. 1B, Table 1) and R-on-T ventricu-
lar extrasystoles (Fig. 1C). Some of the extrasys-
toles triggered numerous episodes of paroxysmal
ventricular tachycardia (Fig. 1D). A dose of 150 mg
of amiodarone in bolus injection terminated the
tachycardia for several minutes. Because of the
relapse of ventricular arrhythmias, continuous ami-
odarone infusion was started (300 mg of amiodar-
one in 5% glucose at a velocity of 6.2 ml/h). Owing
to hypotonia and electrolytic disturbances (Table 1)
fluids containing KCl and CaCO3 were administered
intravenously. During the two-hour amiodarone
infusion we observed clinically significant bradycar-
dia (5530/min), hypotension and elongation of the
QT interval to 0.79 s. We discontinued the drug
administration, introduced an endocavital electrode
and forced stimulation with a frequency of 90/min.
We observed a shortening of the QT interval to 0.46 s
(Fig. 1E) and resolution of the symptoms of cardio-
genic crisis. Nine hours after admission to the de-
partment temporary electrostimulation was switched
off. In ECG monitoring we initially observed sinus
rhythm 82/min (QTc 0.6) but after about 60 minutes
Table 1. Presents some of the pathological findings in physical examination, QTc (corrected QT inter-
val) and major biochemical results in course of hospitalisation.
Parameter Norm 15.09.2003 16.09.2003 22.09.2003 08.10.2003
0.00 2.00 6.00
Temperature 34.7°C 35.8°C 36.0°C 36.1°C 36.1°C
Blood pressure 70/40 90/60 110/60 120/70 135/95
[mm Hg]
Heart rhythm [1/min] 56 55 91 60 64 88
QTc [s] 0.71 0.66 0.62 0.54 0.34 0.43
by Bazetts formula (stymulate) (stymulate)
TSH [µlU/mL] 0.494.67 246.6 174.9 8.14
fT3 [pg/mL] 1.453.48 0.66
fT4  [ng/dL] 0.711.85 0.33
Na+ [mmol/L] 137149 141 141 138 132
K+ [mmol/L] 3.65.0 3.4 4.4 4.8 4.50
Ca2+ [mmol/L] 2.202.75 1.95 2.64 2.43
Creatinine [mmol/L] 44124 159 115 65 97
Anty-TPO [IU/ml] < 100 1375
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bradycardia (about 50 beats per minute) appeared
with episodes of paroxysmal ventricular tachycar-
dia of 150200 beats per minute. We decided to con-
tinue the electrostimulation. The first oral dose of
50 µg of L-thyroxine was given eight hours after
admission to the hospital. After laboratory tests,
which revealed a very low concentration of free thy-
roxine and a high concentration of thyroid-stimulat-
ing hormone (Table 1), the drug dose was increased
to 150 mg per day.
During the second day of hospitalisation, after
compensating for electrolyte deficiency, external
stimulation was discontinued. In ECG and telemet-
ric monitoring stable regular sinus rhythm (5269/
min) remained and there were no marked decreas-
es in blood pressure (Table 1). Ventricular tachy-
cardia did not return and consequently we stopped
the electrostimulation and removed the endocavi-
tal electrode. Within the next few days QTc was
within the range 0.42 to 0.44.
In the echocardiograph performed on the third
day of hospitalisation only impairment of the relax-
ation of the left ventricle was recorded. After one
week of L-thyroxine supplementation the defect of
relaxation disappeared. In neither examination were
contraction disturbances, valve disorders or the
presence of fluid in the pericardium observed.
During the first few days of hospitalisation we
administered hydrocortisone because of the pos-
sibility of concomitant adrenal insufficiency due to
autoimmune disease. On the fifth day of the treat-
ment a short cosynotropin stimulation test was
Figure 1. A. Torsade de pointes paroxysmal ventricular tachycardia registered prior to hospitalisation (by an Emer-
gency Ambulance Unit) in a patient with a hypometabolic crisis; B. Prolongation of QT interval and multifocal
ventricular extrasystoles prior to onset of endocavitar electrode stimulation; C. Ventricular R-on-T extrasystoles
(pointer); D. Ventricular extrasystoles and ventricular tachycardia triggered by R-on-T extrasystoles registered on
telemetry; E. Endocavitar electrode-evoked rhythm.
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conducted, which excluded the suspicion of adre-
nal insufficiency, and after this hydrocortisone was
withdrawn. The patient was discharged from hos-
pital in good general condition. She was put in the
care of the endocrinological outpatient clinic. Fi-
nally, we diagnosed cardiogenic and hypometabolic
shock in the course of TdP-type ventricular ar-
rhythmias secondary to LQT S in a patient with
profound hypothyroidism. In ECG performed one
year after the hospitalisation the QT interval was
normal.
Discussion
The physiological chronotropic response and
normal tension of the heart muscle in diastolic phase
depend on the proper expression of tri-iodothyronine in
the heart cells and its stimulating influence on Na+-K+
ATPase and Ca2+ ATPase in endoplasmic reticulum.
Normal heart contractility is also related to proper
tri-iodothyronine-stimulated transcription of the
myosin heavy-chain alpha gene and inhibition of the
heavy-chain beta gene. Moreover, proper tri-io-
dothyronine expression in the cardiac muscle affects
the number of b-adrenergic receptors and their sen-
sitivity to catecholamines [8].
Profound hypothyroidism and decreased ex-
pression of tri-iodothyronine in the heart cells may
cause a worsening of cardiac contractility, a decreas-
ing heart rate and a slowing down of the conduc-
tion of electrical stimuli in the heart muscle. This
may be the reason for bradycardia and elongation
of the QT interval and, in consequence, life-threat-
ening arrhythmias may occur, for example TdP-type
tachycardia.
Decreased tri-iodothyronine expression and
electrolyte disorders such as moderate hypokalae-
mia and hypocalcaemia probably prompted LQTS
and shock in this case. It is important to note that
amiodarone was not sufficiently effective to prevent
recurrent ventricular arrhythmias. Few publications
report that lignocaine or bretylium tosylate may
interrupt this kind of paroxysmal tachycardia [4].
In this case significant bradycardia and marked elon-
gation of the QT interval limited the possibility of
applying anti-arrhythmic drugs. This is why an en-
docavital electrode was introduced. During cardiac
stimulation we observed shortening of the QT inter-
val and disappearance of the ventricular arrhythmi-
as. Fast L-thyroxine supplementation caused phys-
iological heart-rate acceleration, progressive short-
ening of the QT interval and ECG normalisation.
Conclusions
1. Hypothyroidism may be the cause of life-
-threatening arrhythmias secondary to acquired
long QT syndrome.
2. Ventricular electrostimulation was a life-sav-
ing procedure in this case of prolonged QT syn-
drome and ventricular arrhythmias in the
course of hypometabolic crisis.
3. The use of temporary ventricular electrostim-
ulation protected the patient against dangerous
ventricular arrhythmias, while balancing the
deficiency of thyroid hormones and electrolytes.
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